Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.

Stoch, S Aubrey

Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. [electronic resource] - The Journal of rheumatology Aug 2009 - 1705-14 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

0315-162X

10.3899/jrheum.081207 doi


Administration, Oral
Adult
Aged
Alendronate--administration & dosage
Biomarkers--metabolism
Bone Density--drug effects
Bone Density Conservation Agents--administration & dosage
Calcium--administration & dosage
Drug Therapy, Combination
Female
Glucocorticoids--adverse effects
Hip Joint--drug effects
Humans
Lumbar Vertebrae--drug effects
Male
Middle Aged
Osteoporosis--chemically induced
Placebos
Rheumatic Diseases--drug therapy
Vitamin D--administration & dosage